Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2, Randomized, Double-blind, Placebo-controlled, Multi-center Study of STMC-103H in Neonates and Infants at Risk for Developing Allergic Disease

NCT05003804 is registered in ClinicalTrials.gov with Siolta Therapeutics, Inc. as lead sponsor.

NCT NCT05003804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05003804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2, Randomized, Double-blind, Placebo-controlled, Multi-center Study of STMC-103H in Neonates and Infants at Risk for Developing Allergic Disease
Lead sponsor
Siolta Therapeutics, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
September 1, 2021
Completion date
October 21, 2025
Enrollment
283 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, type 1 hypersensitivity